Gene · 4157
Papers3,724
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 3,724
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Melanocortin 1 receptor variants and their association with phenotypic characteristics and sporadic multiple primary melanomas in a cohort of 402 Spanish subjects. | Exp Dermatol | 2023 | 36602233 | PubTator, text mining | PubMed |
| Molecular underpinnings of exceptional response in primary malignant melanoma of the esophagus to anti-PD-1 monotherapy. | J Immunother Cancer | 2023 | 36593066 | PubTator, text mining | PubMed |
| Investigation of phenyllactic acid as a potent tyrosinase inhibitor produced by probiotics. | Curr Res Food Sci | 2023 | 36569188 | PubTator, text mining | PubMed |
| Phylogenomics Reveals that Mitochondrial Capture and Nuclear Introgression Characterize Skua Species Proposed to be of Hybrid Origin. | Syst Biol | 2023 | 36546866 | PubTator, text mining | PubMed |
| Population-based analysis of POT1 variants in a cutaneous melanoma case-control cohort. | J Med Genet | 2023 | 36539277 | PubTator, text mining | PubMed |
| Genetic architecture and evolution of color variation in American black bears. | Curr Biol | 2023 | 36528024 | PubTator, text mining | PubMed |
| Induced pluripotent stem cells reprogramming overcomes technical limitations for highly pigmented adult melanocyte amplification and integration in 3D skin model. | Pigment Cell Melanoma Res | 2023 | 36478412 | PubTator, text mining | PubMed |
| A homozygous AP3D1 missense variant in patients with sensorineural hearing loss as the leading manifestation. | Hum Genet | 2023 | 36445457 | PubTator, text mining | PubMed |
| Prediction and association analyses of skin phenotypes in Japanese females using genetic, environmental, and physical features. | Skin Res Technol | 2023 | 36437544 | PubTator, text mining | PubMed |
| Hematopoietic-specific melanocortin 1 receptor signaling protects against nephrotoxic serum nephritis and mediates the beneficial effect of melanocortin therapy. | Kidney Int | 2023 | 36374665 | PubTator, text mining | PubMed |
| Increasing Skin Cancer Prevention in Young Adults: the Cumulative Impact of Personalized UV Photography and MC1R Genetic Testing. | J Cancer Educ | 2023 | 36306029 | PubTator, text mining | PubMed |
| Mutually exclusive genetic interactions and gene essentiality shape the genomic landscape of primary melanoma. | J Pathol | 2023 | 36219477 | PubTator, text mining | PubMed |
| Melanoma-specific survival before and after inclusion in a familial melanoma dermatologic surveillance program in CDKN2A mutation carriers and non-carriers. | J Eur Acad Dermatol Venereol | 2023 | 36156317 | PubTator, text mining | PubMed |
| Evidence-based consensus guidelines for the diagnosis and management of erythropoietic protoporphyria and X-linked protoporphyria. | J Am Acad Dermatol | 2023 | 36041558 | PubTator, text mining | PubMed |
| Protein palmitoylation in cancer: molecular functions and therapeutic potential. | Mol Oncol | 2023 | 36018061 | PubTator, text mining | PubMed |
| Multiple primary melanoma in association with other personal and familial cancers. | Cancer Med | 2023 | 35932099 | PubTator, text mining | PubMed |
| Clinical and molecular change induced by repeated low-dose visible light exposure in both light-skinned and dark-skinned individuals. | Photodermatol Photoimmunol Photomed | 2023 | 35861041 | PubTator, text mining | PubMed |
| Melanocortin-1 Receptor (MC1R) Gene Variants are Not Associated With Vascular Brain Alterations. | Actas Dermosifiliogr | 2023 | 35843294 | PubTator, text mining | PubMed |
| Neural crest cells as a source of microevolutionary variation. | Semin Cell Dev Biol | 2023 | 35718684 | PubTator, text mining | PubMed |
| Genome-wide DNA methylome and transcriptome changes induced by inorganic nanoparticles in human kidney cells after chronic exposure. | Cell Biol Toxicol | 2023 | 34973136 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4157/papers?page=24